Removal of alpha-gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase A

Journal of Korean Medical Science

Volumn 24, Issue 6, 2009, Pages 1126-1131

  Park, Seongsik ^a   Kim, Woong Han ^b   Choi, Sun Young ^b   Kim, Yong Jin ^a,b  

^a Dankook University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Alpha galactosidase; Alpha galactosyl epitope; Bioprosthesis

Indexed keywords

ALPHA GALACTOSIDASE; EPITOPE; RECOMBINANT PROTEIN;

ADOLESCENT; ANIMAL; AORTA VALVE; ARTICLE; CHEMISTRY; CHILD; COFFEE; CYTOLOGY; ENZYMOLOGY; GENETICS; HEART VALVE REPLACEMENT; HUMAN; IMMUNOLOGY; PERICARDIUM; SWINE; XENOGRAFT;

ADOLESCENT; ALPHA-GALACTOSIDASE; ANIMALS; AORTIC VALVE; CHILD; COFFEA; EPITOPES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PERICARDIUM; RECOMBINANT PROTEINS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 75349103556     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.6.1126     Document Type: Article

References (18)

1. Jamieson WR, Rosado LJ, Munro AI, Gerein AN, Burr LH, Miyagishima RT, Janusz MT, Tyers GF. Carpentier-Edwards standard porcine bioprosthesis: primary tissue failure (structural valve deterioration) by age groups. Ann Thorac Surg 1988; 46: 155-62.
2. Konakci KZ, Bohle B, Blumer R, Hoetzenecker W, Roth G, Moser B, Boltz-Nitulescu G, Gorlitzer M, Klepetko W, Wolner E, Ankersmit HJ. Alpha-Gal on bioprosthesis: xenograft immune response in cardiac surgery. Eur J Clin Invest 2005; 35: 17-23.
3. Oriol R, Ye Y, Koren E, Cooper DK. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433-42.
4. Goldstein IJ, Blake DA, Ebisu S, Williams TJ, Murphy LA. Carbohydrate binding studies on the Bandeiraea simplicifolia 1 isolectins. Lectins which are mono-, di-, tri-, and tetravalent for N-acetyl-Dgalactosamine. J Biol Chem 1981; 256: 3890-3.
5. Goldstein IJ, Winter HG. The Griffonia simplicifolia 1-B4 isolectin. A probe for alpha-D-galactosyl end groups. Subcell Biochem 1999; 32: 127-41.
6. Kirkeby S, Moe D. Binding of Griffonia simplicifolia 1 isolectin B4 (GS1 B4) to α-galactose antigens. Immunol Cell Biol 2001; 79: 121-7.
7. LaVecchio JA, Dunne AD, Edge AS. Enzymatic removal of alphagalactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation 1995; 60: 841-7.
8. Stone KR, Ayala G, Goldstein J, Hurst R, Walgenbach A, Galili U. Porcine cartilage transplants in the cynomolgus monkey: III Transplantation of α-galactosidase treated porcine cartilage. Transplantation 1998; 65: 1577-83.
9. Luo Y, Wen J, Luo C, Cummings RD, Cooper DK. Pig xenogeneic antigen modification with green coffee bean alpha-galactosidase. Xenotransplantation 1999; 6: 238-48.
10. Park S, Kim WH, Kim KH, Lee CH, Choi SY, Lee C, Oh SS, Kim KC, Kim YJ. Removal of alpha-Gal epitopes in aortic valve and pericardium of pig using green coffee bean α-galactosidase. Kor J Thorac Cardiovasc Surg 2008; 41: 12-24.
11. Treasure T. Rethink on biological aortic valves for the elderly. Lancet 1999; 354: 964-5.
12. The United Kingdom Heart Valve Registry Report 1997. London: UK Heart valve registry, Imperial College School of Medicine, Hammersmith Hospital, 1999.
13. David TE, Ivanov J. Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves? J Thorac Cardiovasc Surg 2003; 126: 939-41.
14. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, Ball S, Specht SM, Polejaeva IA, Monahan JA, Jobst PM, Sharma SB, Lamborn AE, Garst AS, Moore M, Demetris AJ, Rudert WA, Bottino R, Bertera S, Trucco M, Starzl TE, Dai Y, Ayares DL. Production of (α)1,3-galactosyltransferase deficient pigs. Science 2003; 299: 411-4.
15. Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, Monahan JA, Jobst PM, McCreath KJ, Lamborn AE, Cowell-Lucero JL, Wells KD, Colman A, Polejaeva IA, Ayares DL. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20: 251-5.
16. Pisani A, Spinelli L, Sabbatini M, Andreucci MV, Procaccini D, Abbaterusso C, Pasquali S, Savoldi S, Comotti C, Cianciaruso B. Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement. Am J Kidney Dis 2005; 46: 120-7.
17. Wanner C. Fabry disease model: a rational approach to the management of Fabry disease. Clin Ther 2007; 29 (Suppl A): S2-5.
18. Galili U, Latemple DC, Radic MZ. A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody. Transplantation 1998; 65: 1129-32.